These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2717273)

  • 21. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study.
    Kabir Z; Long J; Reddaiah VP; Kevany J; Kapoor SK
    Bull World Health Organ; 2003; 81(4):244-50. PubMed ID: 12764490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study.
    Aaby P; Jensen H; Gomes J; Fernandes M; Lisse IM
    Int J Epidemiol; 2004 Apr; 33(2):374-80. PubMed ID: 15082643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
    Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in east Africa.
    Burström B; Aaby P; Mutie DM
    East Afr Med J; 1995 Mar; 72(3):155-61. PubMed ID: 7796766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trend of measles morbidity in Thailand.
    Ariyasriwatana C
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S707-18. PubMed ID: 14700171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau.
    Aaby P; Biai S; Veirum JE; Sodemann M; Lisse I; Garly ML; Ravn H; Benn CS; Rodrigues A
    Vaccine; 2007 Jan; 25(7):1265-9. PubMed ID: 17092614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008.
    van den Ent MM; Brown DW; Hoekstra EJ; Christie A; Cochi SL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S18-23. PubMed ID: 21666160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau.
    Aaby P; Bukh J; Lisse IM; Smits AJ
    J Infect; 1984 Jan; 8(1):13-21. PubMed ID: 6699411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of measles vaccination on childhood mortality in rural Bangladesh.
    Koenig MA; Khan MA; Wojtyniak B; Clemens JD; Chakraborty J; Fauveau V; Phillips JF; Akbar J; Barua US
    Bull World Health Organ; 1990; 68(4):441-7. PubMed ID: 2208557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The evolution of measles morbidity and mortality in Romania after the introduction of antimeasles vaccination].
    Cazacu E; Bălan A; Dinică V
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):35-44. PubMed ID: 7981527
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage.
    Aaby P; Knudsen K; Jensen TG; Thårup J; Poulsen A; Sodemann M; da Silva MC; Whittle H
    J Infect Dis; 1990 Nov; 162(5):1043-8. PubMed ID: 2230232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A non-specific, beneficial effect of measles vaccination. Analysis of mortality studies from developing countries].
    Aaby MP; Samb B; Simondon F; Seck AM; Knudsen KM; Whittle H
    Ugeskr Laeger; 1996 Oct; 158(42):5944-8. PubMed ID: 8928283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe measles outbreak in western Kenya.
    Burström B; Aaby P; Mutie DM; Kimani G; Bjerregaard P
    East Afr Med J; 1992 Aug; 69(8):419-23. PubMed ID: 1396206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
    Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical epidemiology of pediatric patients with measles from 2000 to 2009 in shanghai, china.
    Ye Y; Wang W; Wang X; Yu H
    Clin Pediatr (Phila); 2011 Oct; 50(10):916-22. PubMed ID: 21561935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroconversion following measles immunisation.
    Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
    Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.